IsoPlexis rallies $25 mln Series C
Branford, Connecticut-based IsoPlexis, a biotechnology company, has raised $25 million in Series C funding. Northpond Ventures led the round.
14 May 2019•1 min read
Branford, Connecticut-based IsoPlexis, a biotechnology company, has raised $25 million in Series C funding. Northpond Ventures led the round.
